Clinical Utility of Plasma Cell-Free DNA EGFR Mutation Analysis in Treatment-Naïve Stage IV Non-Small Cell Lung Cancer Patients

Background: Plasma cell-free Deoxyribo nucleic acid epidermal growth factor receptor (EGFR) mutation tests are widely used at initial diagnosis and at progression in stage IV non-small cell lung cancer (NSCLC). We analyzed the factors associated with plasma EGFR mutation detection and the effect of...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Bo-Guen, Jang, Ja-Hyun, Kim, Jong-Won, Shin, Sun Hye, Jeong, Byeong-Ho, Lee, Kyungjong, Kim, Hojoong, Kwon, O Jung, Ahn, Myung-Ju, Um, Sang-Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880481/
https://www.ncbi.nlm.nih.gov/pubmed/35207417
http://dx.doi.org/10.3390/jcm11041144

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880481/
https://www.ncbi.nlm.nih.gov/pubmed/35207417
http://dx.doi.org/10.3390/jcm11041144

Ejemplares similares